Zero Hedge reports on just about every auction of US debt, short and long-term. You can also track it directly at the US Treasury website. As readers know, I am currently obsessed with our debt disaster, which I think is far past the tipping point to being irrecoverable. So I watch these auctions carefully. The very short term ones, two years or less, haven’t been dreadful. Any longer maturity is a completely different story. And yesterday’s 5 year note auction was spectacularly bad. The amount was $61 billion which is staggering in itself. As I have been saying, it looks to me like supply and demand are the determining factors now in the rates on the longer-term instruments, not whatever the Federal Reserve tries to set rates at. And buyers just aren’t that interested in this product. The end yield was 4.055%, well above what the Treasury planned to sell them at. The bids to amount offered ratio was bad and dealers were left holding the bag on a large part of the auction. Trillions in new and rollover debt will be issued this year and we can expect more auctions like this one. (ZH Post)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
May 8, 2024
Specialty Drug Pricing
One substantial cause of high and growing health care spending is the cost of specialty…
Commentary
May 7, 2024
Venture Capital in 2023
The venture capital community is still struggling with exits and poor investments.
Commentary
May 6, 2024
Drug Spending and Pricing
US drug spending remains high, with more expensive drugs continuing to come on the market…